12 Years Later: Court Prohibits Marketing of Prescription Versions of OTC Drug

In a big win for the Food and Drug Administration (FDA), the D.C. Circuit of the United States Court of Appeals reinforced FDA’s position on what constitutes a “meaningful difference” between prescription and over-the-counter (OTC) versions of a drug product.

Click here to view the full article.

The post 12 Years Later: Court Prohibits Marketing of Prescription Versions of OTC Drug appeared first on Focus on Regulation.

Back to main blog
Loading data